# EUGIA Pharma Specialities Limited, Riico Industrial Area, India – FDA Inspections

Source: https://www.keypedia.com/companies/eugia-pharma-specialities-limited/c9c73721-7ca2-4457-89c9-f1001123e141

> Inspection records and compliance data for EUGIA Pharma Specialities Limited in Riico Industrial Area. 6 FDA inspections on record (2 OAI), 2 Form 483s, last inspected November 14, 2025.

---

## Details

- Name: EUGIA Pharma Specialities Limited
- FEI Number: 3009883410
- Facility Type: Manufacturing Facility
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK
- Address Line 1: Unit - 2, A - 1128 & B - 1127 Bhiwadi
- City: Riico Industrial Area
- Country Name: India
- Address: Unit - 2, A - 1128 & B - 1127 Bhiwadi, Riico Industrial Area, India
- Country: India

## Related Documents

- [483 - EUGIA Pharma Specialities Limited - 2025-11-14](https://www.keypedia.com/records/483/eugia-pharma-specialities-limited/75751173-cc77-4148-9d2c-be0ba4dbebec) — source: FDA, date: November 14, 2025
- FDA Inspection 1297436 - EUGIA Pharma Specialities Limited - 2025-11-14 — source: FDA, date: November 14, 2025
- [FDA Inspection 1297436 - EUGIA Pharma Specialities Limited - 2025-11-14](https://www.keypedia.com/records/fda_inspections/eugia-pharma-specialities-limited/f2e2858d-e654-47a0-8c3b-b5e6ecfc5cbc) — classification: Official Action Indicated (OAI), source: FDA, date: November 14, 2025
- [483 - EUGIA Pharma Specialities Limited - 2024-05-03](https://www.keypedia.com/records/483/eugia-pharma-specialities-limited/2100530d-b507-419b-8d24-6840d66f73b3) — source: FDA, date: May 3, 2024
- [FDA Inspection 1238749 - EUGIA Pharma Specialities Limited - 2024-05-03](https://www.keypedia.com/records/fda_inspections/eugia-pharma-specialities-limited/3355411d-e41b-4c80-996a-52a2f30284df) — classification: Official Action Indicated (OAI), source: FDA, date: May 3, 2024
- FDA Inspection 1227549 - EUGIA Pharma Specialities Limited - 2022-06-24 — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 24, 2022
- [FDA Inspection 1155857 - EUGIA Pharma Specialities Limited - 2019-01-18](https://www.keypedia.com/records/fda_inspections/eugia-pharma-specialities-limited/0b45b044-e8e0-46be-bc20-672757b1c2b5) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 18, 2019
- [483 - EUGIA Pharma Specialities Limited - 2018-03-06](https://www.keypedia.com/records/483/eugia-pharma-specialities-limited/d9cb86c0-e5ad-44af-927a-41fd164955d9) — source: FDA, date: March 6, 2018
- [FDA Inspection 1043313 - EUGIA Pharma Specialities Limited - 2018-03-06](https://www.keypedia.com/records/fda_inspections/eugia-pharma-specialities-limited/6984cbd9-95ca-4846-8461-186168759097) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 6, 2018
- [FDA Inspection 944865 - EUGIA Pharma Specialities Limited - 2015-09-25](https://www.keypedia.com/records/fda_inspections/eugia-pharma-specialities-limited/d5ab688f-57e4-4669-b90b-3bb8eb2f25b1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 25, 2015

## Related Companies

- [AstraZeneca Pharmaceuticals LP](https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/6f9abb75-9352-43df-b761-026089396fa3)
- [Torrent Pharmaceuticals Limited](https://www.keypedia.com/companies/torrent-pharmaceuticals-limited/801e26ba-26ed-40ab-84c9-d4ee2e24e42e)
- [NerPharMa S.r.l.](https://www.keypedia.com/companies/nerpharma-srl/12f11f8a-e70e-4598-807c-a1571bab0391)
- [Takeda Pharmaceutical Company Limited](https://www.keypedia.com/companies/takeda-pharmaceutical-company-limited/0f6bd1ca-94a2-41f0-a8dd-1af20069e6cf)
- [Apothecon Pharmaceuticals Private Limited](https://www.keypedia.com/companies/apothecon-pharmaceuticals-private-limited/9fd69fd5-d0ef-458e-bdf3-b9b73b75f954)
- [Adare Pharmaceuticals, Inc.](https://www.keypedia.com/companies/adare-pharmaceuticals-inc/b1aa5308-ecbd-4a48-adf0-0ed6bd2470c5)
- [Tianish Laboratories Private Limited](https://www.keypedia.com/companies/tianish-laboratories-private-limited/7b05f5f2-461b-4a95-bfaa-a8c773250712)
- [ACS Dobfar SPA (Plant #2)](https://www.keypedia.com/companies/acs-dobfar-spa-plant-2/334c9ae3-385e-4162-a53a-d53e34111e29)
- [Latina Pharma S.p.A.](https://www.keypedia.com/companies/latina-pharma-spa/9cb7e758-39a0-4b4c-bfad-93d1468f5d38)
- [Gland Pharma Limited](https://www.keypedia.com/companies/gland-pharma-limited/9d02bb1e-32f9-45c5-9b90-f52622553c63)

## Related Officers

- [Consumer Safety Officer ](https://www.keypedia.com/people/anastasia-m-shields/a22b8d52-e3f9-4e61-aa3f-6f03ff2f59df)
- [Carrie A. Hughes](https://www.keypedia.com/people/carrie-a-hughes/099d1128-0ba9-4e7a-a0d2-8c10083811c9)
- [Vaishali J. Patel](https://www.keypedia.com/people/vaishali-j-patel/3d515b84-e0fd-4f96-914c-f7f09e2de307)
- [Research Specialist II](https://www.keypedia.com/people/justin-a-boyd/796c9c9d-02db-486c-bdca-cc259066a0e2)
- [Consumer Safety Officer/ Federal Investigator](https://www.keypedia.com/people/lisa-l-flores/465a6807-55d7-4c3f-a415-c21ac4517bc9)
- [Quality System Specialist](https://www.keypedia.com/people/jose-e-melendez/75bd6083-14a4-4bd2-a0e5-9946d4dd37e1)